• Profile
Close

Timing of etonogestrel implant insertion after dilation and evacuation: A randomized controlled trial

Obstetrics and Gynecology May 09, 2018

Cowett AA, et al. - In this randomized controlled trial, the 6-month use rate of the etonogestrel implant placed immediately after dilation and evacuation (D&E) with placement 2–4 weeks postprocedure were compared. Researchers found that women were more likely to be using the etonogestrel implant at 6 months after D&E if they underwent immediate compared with delayed insertion, however, the very high loss to follow-up rate makes it difficult to draw conclusions about the acceptability of the device and pregnancy rates.

Methods

  • In this randomized controlled trial, women seeking abortion between 14 0/7 and 23 5/7 weeks of gestation and desiring the etonogestrel contraceptive implant at an urban family planning clinic were included.
  • Members were randomized to device insertion immediately after the D&E compared with delayed insertion in 2–4 weeks.
  • Implant use rate at 6 months after insertion was the primary outcome and was determined by follow-up phone interviews.
  • Repeat pregnancy rates and method satisfaction were the included secondary outcomes.
  • The sample size of 120 members was calculated based on a power of 0.80 to demonstrate a 20% difference in implant use rates between groups assuming 40% of women overall are not using the device 6 months after the procedure.

Results

  • 148 participants were enrolled between November 2015 and October 2016.
  • 73 members (49.3%) were randomized to and underwent immediate implant insertion after D&E.
  • However, the remaining 75 (50.6%) were randomized to delayed insertion.
  • No significant differences in sociodemographic characteristics between the groups were found.
  • Findings revealed that placement rate was 100% in the immediate group compared with 42.7% in the delayed group (P<.01).
  • At 6 months, 40 of 43 (93%) women from the immediate group who completed follow-up continued use of the implant, on the other hand 19 of 30 (63.3%) women from the delayed group who completed follow-up were using the device (P=.002).
  • It was noted that follow-up rates were low at 58.9% in the immediate group compared with 40.0% in the delayed group.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay